Company Filing History:
3 out of 1,035 
3 out of 17 
Years Active: 2012-2014
Title: Mark Heffernan: Innovator in Growth Hormone Research
Introduction
Mark Heffernan is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of biotechnology, particularly in the modulation of growth hormone receptor expression and insulin-like growth factor expression. With a total of three patents to his name, Heffernan's work has implications for the diagnosis and treatment of diseases associated with these growth factors.
Latest Patents
Heffernan's latest patents focus on compounds, compositions, and methods for modulating the expression of growth hormone receptors and insulin-like growth factor-I (IGF-I). These compositions include oligonucleotides targeted to nucleic acids encoding growth hormone receptors. The methods provided in these patents are designed for the modulation of growth hormone receptor expression and for the diagnosis and treatment of diseases linked to the expression of these growth factors. Additionally, diagnostic methods and kits are included in his patents, showcasing the practical applications of his research.
Career Highlights
Throughout his career, Mark Heffernan has worked with prominent companies in the biotechnology sector. He has been associated with Isis Pharmaceuticals, Inc. and Antisense Therapeutics Limited, where he has contributed to various innovative projects. His expertise in the field has allowed him to make substantial advancements in understanding growth hormone mechanisms.
Collaborations
Heffernan has collaborated with notable professionals in his field, including George Tachas and Kenneth W. Dobie. These collaborations have further enriched his research and have led to significant advancements in the understanding of growth hormone receptor modulation.
Conclusion
Mark Heffernan's contributions to the field of biotechnology, particularly in the modulation of growth hormone receptors, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving diagnostic methods.